Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial

Abstract Background Patients with acute myocardial infarction are at greater risk for chronic heart failure and mortality. Currently, there is limited evidence supporting the beneficial effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in non-diabetic patients with redu...

Full description

Bibliographic Details
Main Authors: Sajad Khiali, Mohammadreza Taban-Sadeghi, Parvin Sarbakhsh, Naser Khezerlouy-Aghdam, Hossein Namdar, Rezvanieh Salehi, Afra Rezagholizadeh, Taher Entezari-Maleki
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Trials
Subjects:
Empagliflozin
Colchicine
Myocardial infarction
Heart failure
LVSD
Clinical trial
Online Access:https://doi.org/10.1186/s13063-023-07682-6

Internet

https://doi.org/10.1186/s13063-023-07682-6

Similar Items